The relationship between serum ferritin levels and disease activity in systemic lupus erythematosus

被引:51
|
作者
Beyan, E
Beyan, C [1 ]
Demirezer, A
Ertugrul, E
Uzuner, A
机构
[1] Gulhane Mil Med Acad, Dept Hematol, TR-06010 Etlik, Turkey
[2] Gulhane Mil Med Acad, Dept Internal Med, Numune Educ & Res Hosp, TR-06010 Etlik, Turkey
关键词
systemic lupus erythematosus; serum ferritin; SLEDAI; acute phase response;
D O I
10.1080/03009740310003712
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The aim of this study is to investigate the relationship between serum ferritin levels and disease activity in patients with systemic lupus erythematosus (SLE). Methods: Serum ferritin levels of 72 SLE patients were measured. The SLE patients were subdivided into two groups according to SLE disease activity index (SLEDAI) as less than or equal to10 and greater than or equal to11. The results were compared with 31 patients with rheumatoid arthritis (RA). 36 patients among 72 with SLE were evaluated before and after treatment. Results: Serum levels of ferritin in SLE patients were higher than RA patients (p < 0,001). There was a significant difference in ferritin levels before and after treatment. The levels of ferritin in SLE were positively correlated with SLEDAI scores. Patients with SLEDAI scores ≥11 had significantly higher serum ferritin levels. Conclusion: Serum ferritin levels may be a useful marker of disease activity in SLE patients.
引用
收藏
页码:225 / 228
页数:4
相关论文
共 50 条
  • [1] Serum ferritin as a serologic marker of activity in systemic lupus erythematosus
    Lim, MK
    Lee, CK
    Ju, YS
    Cho, YS
    Lee, RS
    Yoo, B
    Moon, HB
    RHEUMATOLOGY INTERNATIONAL, 2001, 20 (03) : 89 - 93
  • [2] Cytokine production, serum levels and disease activity in systemic lupus erythematosus
    Gröndal, G
    Gunnarsson, I
    Rönnelid, J
    Rogberg, S
    Klareskog, L
    Lundberg, I
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2000, 18 (05) : 565 - 570
  • [3] Elevation of serum ferritin levels as a marker for active systemic lupus erythematosus
    Nishiya, K
    Hashimoto, K
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1997, 15 (01) : 39 - 44
  • [4] Relationship between serum lipopolysaccharide binding protein levels, disease activity, and clinical characteristics in Paraguayan patients with systemic lupus erythematosus
    Losanto, Jhonatan
    Langjahr, Patricia
    Barrios, Graciela
    Paats, Astrid
    de Hetter, Maria E. Acosta
    de Guillen, Ivalena
    Duarte, Margarita
    Acosta-Colman, Isabel A.
    Cervera, Ricard
    LUPUS, 2021, 30 (13) : 2089 - 2094
  • [5] Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity
    Robak, E
    Wozniacka, A
    Sysa-Jedrzejowska, A
    Stepien, H
    Robak, T
    EUROPEAN CYTOKINE NETWORK, 2001, 12 (03) : 445 - 452
  • [6] Dehydroepiandrosterone in systemic lupus erythematosus: Relationship between dosage, serum levels, and clinical response
    Barry, NN
    McGuire, JL
    van Vollenhoven, RF
    JOURNAL OF RHEUMATOLOGY, 1998, 25 (12) : 2352 - 2356
  • [7] Serum levels of vitamin D in systemic lupus erythematosus patients (SLE) and their relationship with disease activity: longitudinal study
    Garcia-Carrasco, Mario
    Mendoza-Pinto, Claudia
    Ayon-Aguilar, Jorge
    Soto-Santillan, Pamela
    Rodriguez-Gallegos, Alma
    Antonio Escamilla-Marquez, Marco
    Mendez-Martinez, Socorro
    GACETA MEDICA DE MEXICO, 2016, 152 : 32 - 37
  • [8] Is it useful to measure serum ferritin level in systemic lupus erythematosus patients?
    Gamal, Nada M.
    Khedr, Tayseer M.
    Ismail, Nadia M.
    Ramadan, Heba
    Badawy, Eman R.
    EGYPTIAN RHEUMATOLOGIST, 2020, 42 (01) : 17 - 21
  • [9] Cardiovascular disease and serum defensin levels in systemic lupus erythematosus
    Vordenbaeumen, S.
    Sander, O.
    Bleck, E.
    Schneider, M.
    Fischer-Betz, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (03) : 364 - 370
  • [10] Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity
    Atsushi Tanaka
    Hiroshi Tsukamoto
    Hiroki Mitoma
    Chikako Kiyohara
    Naoyasu Ueda
    Masahiro Ayano
    Shun-ichiro Ohta
    Yasushi Inoue
    Yojirou Arinobu
    Hiroaki Niiro
    Takahiko Horiuchi
    Koichi Akashi
    Arthritis Research & Therapy, 14